Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

intervet ireland limited - bhv-1 strain gk/d inactivated glycoprotein e deficient (ge) bovine herpesvirus 1 - suspension for injection - 60 elisa units - bovine rhinotracheitis virus vaccine (ibr) - bovine - immunological - inactivated vaccine

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - bovine herpes virus type 1 strain difivac - suspension for injection - unknown - bovine rhinotracheitis virus vaccine (ibr) - bovine - immunological - inactivated vaccine

Suurbritannia - inglise - VMD (Veterinary Medicines Directorate)

zoetis uk limited - infectious bovine rhinotraceitis virus - suspension for injection - inactivated viral vaccine - cattle

Suurbritannia - inglise - VMD (Veterinary Medicines Directorate)

boehringer ingelheim animal health uk ltd - foot-and-mouth disease virus - suspension for injection - inactivated viral vaccine - cattle, goats, sheep

Suurbritannia - inglise - VMD (Veterinary Medicines Directorate)

boehringer ingelheim animal health uk ltd - foot-and-mouth disease virus - emulsion for injection - inactivated viral vaccine - cattle, goats, pigs, sheep

Suurbritannia - inglise - VMD (Veterinary Medicines Directorate)

intervet international bv - infectious bovine rhinotraceitis virus - suspension for injection - inactivated viral vaccine - cattle

Euroopa Liit - inglise - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - maximum three of the following purified, inactivated foot-and-mouth disease virus strains: o1 manisa ≥ 6 pd50*; o1 bfs ≥ 6 pd50*; o taiwan 3/97 ≥ 6 pd50*; a22 iraq ≥ 6 pd50*; a24 cruzeiro ≥ 6 pd50*; a turkey 14/98 ≥ 6 pd50*; asia 1 shamir ≥ 6 pd50*; sat2 saudi arabia ≥ 6 pd50*; * pd50 – 50% protective dose in cattle as described in ph. eur. monograph 0063. - immunologicals - pigs; cattle; sheep - active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

Euroopa Liit - inglise - EMA (European Medicines Agency)

merial - inactivated ibr virus - immunologicals for bovidae - cattle - active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion., the onset of immunity is 14 days and the duration of immunity is 6 months.,

Euroopa Liit - inglise - EMA (European Medicines Agency)

merial - bluetongue virus serotype 8 antigen - immunologicals for ovidae, immunologicals for bovidae - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.*(below the level of detection by the validated rt-pcr method at 3.14log10 rna copies/ml, indicating no infectious virus transmission).onset of immunity has been demonstrated 3 weeks after the primary vaccination course.the duration of immunity for cattle and sheep is 1 year after the primary vaccination course.the duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.

Euroopa Liit - inglise - EMA (European Medicines Agency)

zoetis belgium sa - inactivated bluetongue virus, serotype 1 - immunologicals - cattle - active immunisation of cattle from 2½ months of age for the prevention of viraemia caused by bluetongue virus, serotype 1.onset of immunity: 15 days after completion of the primary vaccination course.duration of immunity: 12 months.